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Abstract
Acute salicylate overdose in pregnancy is potentially fatal
for both the mother and fetus and presents a unique chal-
lenge in intensive care management. While suggested
thresholds exist for hemodialysis in adults with toxic sali-
cylate ingestion, it is unclear if these thresholds remain
appropriate for the gravid patient, particularly given that
medications such as acetylsalicylic acid may cross the pla-
cental barrier and accumulate in the fetal bloodstream. We
describe a case of a gravid patient at ~37 weeks gestational
age with a self-reported acetylsalicylic acid ingestion of
32.5 g and review prior cases of both acute and chronic
salicylate ingestion in pregnancy in order to determine the
clinical precedent for hemodialysis in this situation.
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Case report
A 19-year-old, gravida 1, para 0 woman at 39 weeks
gestation with a past medical history notable for mild mental
retardation, bipolar disorder and hypothyroidism presented
to an outside hospital with bloody emesis and tinnitus after a
self-reported ingestion of 100 tablets (32.5 g) of aspirin
several hours prior. Upon initial presentation, she was
agitated and tachypneic, with a respiratory rate of 40
breaths/minute and tachycardic, with a heart rate of 120–
130 beats/minute, but otherwise hemodynamically stable.
Her laboratory data were notable for a salicylate level of
57.5 mg/dL, bicarbonate of 16 mmol/L and an anion gap of
14. An ultrasound showed a fetal heart rate of 160–170
beats/minute. The patient was given bicarbonate and glucose
and transferred to the medical intensive care unit, where she
was continued on a bicarbonate drip for urine alkalinization.
A repeat salicylate level was 41.69 mg/dL with an arterial
pH of 7.60. She remained persistently alkalotic due to the
bicarbonate drip. Coagulation studies, including prothrom-
bin time (PT), activated partial thromboplastin time (PTT)
and international normalized ratio (INR), were all within
normal limits. Her hematocrit was 37% and platelets were
487 000/mm3. The patient remained confused and agitated
and continued to complain of tinnitus. A series of her serum
salicylate levels is shown in Figure 1.
As the threshold for hemodialysis for aspirin overdose at
our institution is a serum salicylate level of 100 mg/dL, the
patient was determined not to be a candidate for hemodial-
ysis. Her serum salicylate level continued to decrease with
intravenous fluids and bicarbonate therapy. A fetal ultra-
sound indicated a gestational age of 37–38 weeks (by fetal
biparietal diameter and femur length). The fetal heart tracing
showed a baseline fetal heart rate of 160–170 beats/minute
with minimal variability and multiple spontaneous deceler-
ations. The patient’s medical and mental status continued to
improve. She also began to contract regularly, with cervical
change to 3 cm dilation, consistent with early labor. The fetal
heart tracing continued to be non-reassuring. Given the
non-reassuring fetal heart tracing and the signs that the
patient was entering early labor, she was extensively coun-
seled as to the risks and benefits of a Cesarean delivery for
both herself and the fetus and she consented to the proce-
dure. To minimize risk of maternal hemorrhage, she was
given a platelet transfusion prior to transfer to the operating
room. A second unit of platelets was also started as the
patient was taken to the operating room for an emergent
Cesarean section under general anesthesia. A vertical skin
incision, rather than a Pfannenstiel incision, was used to
decrease the bleeding risk. Thick meconium was noted at
the time of delivery, but the procedure was otherwise
uncomplicated. Blood loss was estimated at 700 cc.
The female neonate weighed 3100 g at delivery and was
initially limp and apneic with thick meconium-stained fluid.
Apgars were 1 and 7 at 0 and 5 min, respectively. The initial
heart rate was <60 beats/minute and chest compressions
were not performed; the neonate was subsequently intubated.
Arterial and venous cord gases drawn immediately after
delivery were pH 7.32, CO2 43.6 mmHg, base excess
4 and pH 7.36, CO2 36.6 mmHg, and base excess 4.3,
respectively. A salicylate level also drawn at this time was
33.5 mg/dL, while a level drawn simultaneously from the
mother was 27.06 mg/dL. Initial complete blood count
and coagulation studies at 1 h of life revealed a white blood
cell count of 23 900 cells/mm3, hemoglobin 13.6 mmol/L,
hematocrit 40.3%, platelets 285 000/mm3, PT 26.5, PTT
 The Author 2011. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
For permissions, please e-mail: journals.permissions@oup.com
41.6, INR 2.4 and fibrinogen 169. Electrolytes drawn at~6 h of
life were as follows: sodium 137 mEq/L, potassium 2.8 mEq/L,
chloride 101 mmol/L, bicarbonate 17 mmol/L and calcium
7.1 mEq/L. A urine toxicology screen was negative for
amphetamines, barbituates, benzodiazepines, cannabinoids,
cocaine, methadone, opiates and oxycodone. Meconium
toxicology screen returned positive for cannabinoids. A head
ultrasound was performed and showed no intracranial
hemorrhage and no anomalies or malformations. A chest
X-ray also performed shortly after delivery was suggestive
of meconium aspiration syndrome. The neonate received
surfactant via endotracheal tube and was started on intrave-
nous fluids with supplemental bicarbonate. She also received
one transfusion of fresh frozen plasma (10 cc/kg) and platelets
(10 cc/kg) due to the increased INR and mild oozing noted
with placement of the umbilical artery and venous catheters.
Ampicillin and gentamicin were started empirically for a 48-h
course; blood cultures drawn prior to antibiotic therapy
showed no growth after 48 h. She was extubated ~17 h after
delivery and remained stable. The post-natal course was
remarkable for respiratory alkalosis, initial hypokalemia
and hypocalcemia that resolved following repletion and
normoglycemia. Neonatal salicylate levels are also shown
in Table 1. The neonate did not pass a hearing test performed
on day of life two; the results of further testing are unknown.
Discussion
There have been several prior reports of in utero salicylate
toxicity, with three involving acute ingestion [1–3], two
of which resulted in intrauterine fetal demise [2, 3]. The
remaining cases involve chronic daily usage in the last tri-
mester of pregnancy, and in two of such cases [4, 5], fetal or
neonatal death was the result, one in utero [4] and one at day
of life nine [5]. In several cases, the diagnosis of in utero
salicylate exposure was made retrospectively and post-
partum [1, 5–8]. In those cases in which salicylate exposure
was known in the antepartum setting, the outcome was either
intrauterine fetal demise [2–4] or Cesarean section due to fetal
distress [9, 10], although the latter two cases involved chronic
salicylate exposure during pregnancy rather than acute intox-
ication. The treatment in these cases of known in utero sali-
cylate toxicity has largely been expectant management, with
outcomes ranging from fetal demise in utero in the cases
of large-volume ingestion [2–4] to delivery without sequelae,
primarily in the cases of chronic ingestion [6, 7, 10, 11]
although not exclusively [1]. Therefore, in acute maternal
toxic salicylate ingestion, appropriate treatment is unclear,
particularly whether or not dialysis or prompt delivery would
be beneficial in preventing fetal demise in utero.
In adult patients, the threshold for hemodialysis to fur-
ther counteract the effects of salicylates has been suggested
at 70–80 [12] and 100 mg/dL at our institution. However, it
has been noted that the severity of the intoxication does not
always correlate with serum salicylate levels [13]. While
neither our case nor prior cases have met these criteria, the
three cases involving fetal demise in utero involved mater-
nal salicylate levels in the 50–60 mg/dL range [3, 4], and it
has been shown that fetal blood levels are ~1.5 times
maternal levels [9, 11]. Furthermore, the neonate eliminates
salicylate more slowly due to immature glucuronidation and
renal excretory pathways [9, 11], and salicylate tends to
concentrate in the fetal brain due to a smaller intravascular/
intracellular pH gradient in the fetus [4]. The intracerebral
accumulation of salicylates is a major cause of morbidity and
mortality. This raises the question of whether dialysis
should be initiated at lower levels in cases of salicylate
toxicity in pregnancy, and if this might be beneficial for
the fetus. In only one prior report was hemodialysis utilized
[4], and this was initiated in a patient who presented after in
utero fetal demise had already occurred.
To our knowledge, there have been no reports of the use
of dialysis for toxic overdose of any drug in pregnant
patients. There has been a study of acute kidney injury
during pregnancy requiring dialysis [14], but fetal out-
comes were not followed. In our case, a gravid patient
presented with initial salicylate levels below those in prior
case reports where significant morbidity or mortality was
the outcome. Although the fetus showed signs of distress
upon presentation, the decision was made to delay delivery
until maternal status had been optimized. It was unclear
whether the benefits of maternal hemodialysis would be
conferred upon the fetus, as hemodialysis would have little
effect on the salicylate that had already entered fetal circu-
lation. In addition, fetal distress in this situation could be
attributed to derangements in fetal acid–base status, as
mentioned in previous case reports [4], with fetal acidosis
persisting despite our patient’s alkalosis due to intravenous
bicarbonate therapy. Indeed, it has been hypothesized that
maternal hemodialysis does not benefit the fetus in the case
of acute salicylate overdose and that emergent delivery is
the most beneficial for the fetus at risk for in utero salicylate
toxicity at or near term [4]. Maternal hemodialysis was not
initiated in our case, with no adverse effect on fetal outcome.
As shown in Figure 1, neonatal salicylate levels, although
higher than maternal levels, also declined spontaneously
within 24 h of life.
As the patient’s condition stabilized without hemodial-
ysis, she spontaneously began to labor and mode of deliv-
ery became a concern. The fetal heart tracing continued to
show signs of fetal distress, and despite progressive cervi-
cal change, it was thought that the fetus would not tolerate a
vaginal delivery. As salicylate metabolites accumulate in
the fetal brain [5], potentially fatal intracerebral hemor-
rhage could result, as has been reported in other cases
Fig. 1. Maternal and neonatal acetylsalicylic acid levels over time
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[2, 8]. Given these concerns for fetal well-being, a Cesarean
section was determined to be the optimal mode of delivery.
Our experience with this case and further research on
similar situations illustrates that maternal hemodialysis is
of little benefit to the fetus in cases of salicylate ingestion
and that expectant management is reasonable until maternal
condition stabilizes, at which time, the patient should be
counseled for a Cesarean section to avoid fatal fetal intra-
cerebral hemorrhage.
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